Ribavirin Alternatives Compared
Ribavirin | Harvoni | Sovaldi |
|
---|
Ribavirin | Harvoni ledipasvir / sofosbuvir | Sovaldi sofosbuvir |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescribed for Respiratory Syncytial Virus, Hepatitis C. ribavirin may also be used for purposes not listed in this medication guide. |
Harvoni is a combination tablet containing ledipasvir and sofosbuvir. It may be used to treat certain genotypes of the hepatitis C virus in adults and children over the age of three. It is usually... View more |
Sovaldi may be used to treat certain genotypes of the hepatitis C virus in adults and children over the age of three. It must be given in combination with other treatments and cannot be used alone to... View more |
Choose a suggestion below Popular Comparisons
|
|||||||||||||||||||||||
More about Ribavirin | More about Harvoni (ledipasvir / sofosbuvir) | More about Sovaldi (sofosbuvir) | ||||||||||||||||||||||||
Generic Status | ||||||||||||||||||||||||||
No lower-cost generic available |
||||||||||||||||||||||||||
Availability | ||||||||||||||||||||||||||
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Ribavirin has an average rating of 5.1 out of 10 from a total of 10 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 44% reported a negative effect. |
Harvoni has an average rating of 8.6 out of 10 from a total of 396 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 10% reported a negative effect. |
Sovaldi has an average rating of 7.7 out of 10 from a total of 47 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
Commonly reported side effects include: hemolytic anemia, decreased hemoglobin, insomnia, dyspnea, lack of concentration, emotional lability, irritability. See the full ribavirin side effects document. |
See the full Harvoni side effects document. |
See the full Sovaldi side effects document. |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all ribavirin prices |
View all Harvoni prices and generic prices |
View all Sovaldi prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Rebetol, RibaPak, Ribasphere, RibaTab, Virazole |
N/A |
N/A |
||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
960 hours |
47 hours |
27 hours |
||||||||||||||||||||||||
CSA Schedule** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category X
Not for use in pregnancy
See the full Pregnancy Warnings document. |
Category B
No proven risk in humans
See the full Pregnancy Warnings document. |
Category B
No proven risk in humans
Category X
Not for use in pregnancy
In Combination With Ribavirin Or Peginterferon Alfa/Ribavirin See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 18 drugs are known to interact with ribavirin:
|
A total of 164 drugs are known to interact with Harvoni:
|
A total of 73 drugs are known to interact with Sovaldi:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
June 03, 1998 |
October 10, 2014 |
December 06, 2013 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.